Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- 7-valent pneumococcal conjugate vaccine 1
- 13-valent pneumococcal conjugate vaccine 1
- 2019-nCoV Vaccine mRNA-1273 2
- 2019-nCoV Vaccine MRNA-1273 1
- Acute Disease 1
- Adolescent 18
- Adult 19
- Adults 1
- Aged 15
- Aged, 80 and over 3
- Age Distribution 1
- Age Factors 3
- Antibodies, Bacterial 1
- Antibodies, Monoclonal, Humanized 1
- Antibodies, Viral 1
- Antimicrobial Resistance 1
- Antiviral Agents 2
- Anus Diseases 1
- Article 6
- Asthma 1
- Asymptomatic Diseases 1
- B-Lymphocytes 1
- bacteria 2
- Bacteria 1
- BetacoronaVirus 2
- BNT162 Vaccine 3
- California 1
- Case-Control Studies 1
- Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines 1
- Child 10
- Child, Preschool 12
- Chronic Disease 1
- Clinical Laboratory Techniques 1
- Clinical Trials as Topic 1
- Coinfection 1
- Community-Acquired Infections 2
- Community-Acquired Infections/Transmission 1
- Computer Software Application 1
- Condylomata Acuminata 1
- Contact Tracing 1
- CoronaVirus Infections 4
- CoronaVirus Infections/Prevention & Control 2
- CoronaVirus Infections/Prevention & cotrol 1
- CoronaVirus Infections/Transmission 1
- COVID-19 14
- COVID-19 Drug Treatment 1
- COVID-19 Vaccines 10
- COVID-19/Prevention & Control 2
- COVID-19/Prevention & cotrol 1
- Diphtheria-Tetanus-acellular Pertussis Vaccines 1
- Diphtheria-Tetanus-Pertussis Vaccine 1
- Diphtheria Toxoid 1
- Dispatch 2
- Dose-Response Relationship, Immunologic 1
- Emergency Service, Hospital 3
- Empyema, Pleural 1
- Family 1
- Family Characteristics 3
- Female 20
- Frailty 1
- Full Report 1
- Hospitalization 18
- Hospital Mortality 2
- Humans 32
- Immunocompromised Host 2
- Incidence 3
- Infant 7
- Infant, Newborn 3
- Influenza 3
- Influenza, Human 8
- Influenza A Virus, H1N1 Subtype 2
- Influenza Vaccines 6
- Male 19
- Metapneumovirus 3
- Middle Aged 17
- older adults 2
- Pandemics 3
- Paramyxoviridae Infections 2
- Pneumonia 2
- pneumonia 2
- Pneumonia, Viral 5
- Population Surveillance 3
- Prospective Studies 6
- Research Article 2
- Respiration, Artificial 2
- Respiratory Syncytial Viruses 2
- Respiratory Syncytial Virus Infections 2
- Respiratory Tract Infections 3
- Risk Assessment 2
- RNA, Messenger 2
- SARS-CoV-2 7
- Streptococcus pneumoniae 2
- Tennessee 2
- Time Factors 4
- United States 3
- Vaccination 7
- Vaccine Efficacy 4
- Vaccines, Combined 2
- Vaccines, Synthetic 3
- Young Adult 14
Personal Author
Corporate Author
- Baylor Scott & White Health. 4
- Baystate Medical Center, Springfield, Massachusetts 1
- Baystate Medical Center, Springfield, Massachusetts. 2
- Baystate Medical Center. 1
- Beth Israel Deaconess Medical Center. 2
- CDC COVID-19 Emergency Response Team. 1
- CDC COVID-19 Response Team. 3
- CDC COVID- Response Team. 1
- Cleveland Clinic. 2
- Emory University School of Medicine. 2
- for the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study Team 1
- HAIVEN Investigators 1
- Hennepin County Medical Center. 4
- Hospitalized Adult Influenza Vaccine Effectiveness Network. 1
- Intermountain Medical Center (Utah) 1
- Intermountain Medical Center. 1
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah 1
- Intermountain Medical Center and University of Utah. 1
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network 1
- IVY Network 7
- IVY Network. 3
- IVY Network Investigators 1
- IVY Network Investigators. 1
- Johns Hopkins Hospital. 4
- Marshfield Clinic Research Institute. 1
- Montefiore Healthcare Center. 1
- Montefiore Medical Center and Albert Einstein College of Medicine. 3
- Ohio State University. Wexner Medical Center. 2
- Ohio State University Wexner Medical Center. 1
- Oregon Health & Science University Hospital. 3
- Ronald Reagan-UCLA Medical Center. 3
- St. Joseph Mercy Health System (Ann Arbor, Michigan) 1
- Stanford University. School of Medicine. 1
- Stanford University Medical Center. 1
- Stanford University School of Medicine. 1
- Texas A&M University. College of Medicine. 2
- Texas A&M University College of Medicine. 2
- University of Colorado School of Medicine (Aurora) 1
- University of Colorado School of Medicine, Aurora, Colorado 3
- University of Iowa. 3
- University of Miami. 2
- University of Michigan, School of Public Health. 1
- University of Michigan. School of Medicine. 1
- University of Michigan School of Medicine. 1
- University of Michigan School of Public Health. 3
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. 1
- University of Utah. 1
- University of Washington School of Medicine. 3
- Vanderbilt University Medical Center, Nashville, Tennessee. 1
- Vanderbilt University Medical Center. 4
- Wake Forest University. Baptist Medical Center. 1
- Wake Forest University Baptist Medical Center. 3
- Washington University. 2
Place as Subject
- Alabama 1
- Arizona 1
- California 1
- Colorado 2
- Davidson County, TN 1
- Florida 1
- Georgia 1
- Indiana 1
- Iowa 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 2
- Massachusetts 1
- Michigan 1
- Minnesota 2
- Missouri 1
- New Mexico 1
- New York 1
- New York City, NY 1
- North Carolina 2
- Ohio 1
- Oregon 1
- Peru 1
- Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women ☆ 1
- Seattle, WA 1
- Tennessee 10
- Texas 1
- United States 11
- Utah 2
- Washington 1
- Wisconsin 3
Resource Type General
Keywords
- Acute Disease 1
- adherence 1
- Bronchiolitis 1
- Chest 1
- Child, Preschool 1
- Children 1
- COVID-19 1
- death 1
- epidemiology 1
- etiology 1
- Female 1
- hospitalization 1
- household transmission 1
- Human metapneumovirus 1
- Humans 1
- incidence 1
- Infant 1
- Infant, Newborn 1
- Infection 1
- Lungs 1
- Male 1
- Metapneumovirus 1
- palivizumab 1
- Paramyxoviridae Infections 1
- pediatric 1
- pneumonia 1
- Prospective Studies 1
- Radiography 1
- Radiography, Thoracic 1
- respiratory syncytial virus 1
- Respiratory tract 1
- Respiratory Tract Infections 1
- SARS-CoV-2 2
- secondary infection risk 1
- severe disease 1
- viral culture 1
Select all docs (Max 200)
1 -
20 of 42 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- 7-valent pneumococcal conjugate vaccine (1)
- 13-valent pneumococcal conjugate vaccine (1)
- 2019-nCoV Vaccine mRNA-1273 (2)
- 2019-nCoV Vaccine MRNA-1273 (1)
- Acute Disease (1)
- Adolescent (18)
- Adult (19)
- Adults (1)
- Aged (15)
- Aged, 80 and over (3)
- Age Distribution (1)
- Age Factors (3)
- Antibodies, Bacterial (1)
- Antibodies, Monoclonal, Humanized (1)
- Antibodies, Viral (1)
- Antimicrobial Resistance (1)
- Antiviral Agents (2)
- Anus Diseases (1)
- Article (6)
- Asthma (1)
- Asymptomatic Diseases (1)
- B-Lymphocytes (1)
- bacteria (2)
- Bacteria (1)
- BetacoronaVirus (2)
- BNT162 Vaccine (3)
- California (1)
- Case-Control Studies (1)
- Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines (1)
- Child (10)
- Child, Preschool (12)
- Chronic Disease (1)
- Clinical Laboratory Techniques (1)
- Clinical Trials as Topic (1)
- Coinfection (1)
- Community-Acquired Infections (2)
- Community-Acquired Infections/Transmission (1)
- Computer Software Application (1)
- Condylomata Acuminata (1)
- Contact Tracing (1)
- CoronaVirus Infections (4)
- CoronaVirus Infections/Prevention & Control (2)
- CoronaVirus Infections/Prevention & cotrol (1)
- CoronaVirus Infections/Transmission (1)
- COVID-19 (14)
- COVID-19 Drug Treatment (1)
- COVID-19 Vaccines (10)
- COVID-19/Prevention & Control (2)
- COVID-19/Prevention & cotrol (1)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (1)
- Diphtheria-Tetanus-Pertussis Vaccine (1)
- Diphtheria Toxoid (1)
- Dispatch (2)
- Dose-Response Relationship, Immunologic (1)
- Emergency Service, Hospital (3)
- Empyema, Pleural (1)
- Family (1)
- Family Characteristics (3)
- Female (20)
- Frailty (1)
- Full Report (1)
- Hospitalization (18)
- Hospital Mortality (2)
- Humans (32)
- Immunocompromised Host (2)
- Incidence (3)
- Infant (7)
- Infant, Newborn (3)
- Influenza (3)
- Influenza, Human (8)
- Influenza A Virus, H1N1 Subtype (2)
- Influenza Vaccines (6)
- Male (19)
- Metapneumovirus (3)
- Middle Aged (17)
- older adults (2)
- Pandemics (3)
- Paramyxoviridae Infections (2)
- Pneumonia (2)
- pneumonia (2)
- Pneumonia, Viral (5)
- Population Surveillance (3)
- Prospective Studies (6)
- Research Article (2)
- Respiration, Artificial (2)
- Respiratory Syncytial Viruses (2)
- Respiratory Syncytial Virus Infections (2)
- Respiratory Tract Infections (3)
- Risk Assessment (2)
- RNA, Messenger (2)
- SARS-CoV-2 (7)
- Streptococcus pneumoniae (2)
- Tennessee (2)
- Time Factors (4)
- United States (3)
- Vaccination (7)
- Vaccine Efficacy (4)
- Vaccines, Combined (2)
- Vaccines, Synthetic (3)
- Young Adult (14)
- Baylor Scott & White Health. (4)
- Baystate Medical Center, Springfield, Massachusetts (1)
- Baystate Medical Center, Springfield, Massachusetts. (2)
- Baystate Medical Center. (1)
- Beth Israel Deaconess Medical Center. (2)
- CDC COVID-19 Emergency Response Team. (1)
- CDC COVID-19 Response Team. (3)
- CDC COVID- Response Team. (1)
- Cleveland Clinic. (2)
- Emory University School of Medicine. (2)
- for the Centers for Disease Control and Prevention (CDC) Etiology of Pneumonia in the Community (EPIC) Study Team (1)
- HAIVEN Investigators (1)
- Hennepin County Medical Center. (4)
- Hospitalized Adult Influenza Vaccine Effectiveness Network. (1)
- Intermountain Medical Center (Utah) (1)
- Intermountain Medical Center. (1)
- Intermountain Medical Center and University of Utah, Salt Lake City, Utah (1)
- Intermountain Medical Center and University of Utah. (1)
- Investigating Respiratory Viruses in the Acutely Ill (IVY) Network (1)
- IVY Network (7)
- IVY Network. (3)
- IVY Network Investigators (1)
- IVY Network Investigators. (1)
- Johns Hopkins Hospital. (4)
- Marshfield Clinic Research Institute. (1)
- Montefiore Healthcare Center. (1)
- Montefiore Medical Center and Albert Einstein College of Medicine. (3)
- Ohio State University. Wexner Medical Center. (2)
- Ohio State University Wexner Medical Center. (1)
- Oregon Health & Science University Hospital. (3)
- Ronald Reagan-UCLA Medical Center. (3)
- St. Joseph Mercy Health System (Ann Arbor, Michigan) (1)
- Stanford University. School of Medicine. (1)
- Stanford University Medical Center. (1)
- Stanford University School of Medicine. (1)
- Texas A&M University. College of Medicine. (2)
- Texas A&M University College of Medicine. (2)
- University of Colorado School of Medicine (Aurora) (1)
- University of Colorado School of Medicine, Aurora, Colorado (3)
- University of Iowa. (3)
- University of Miami. (2)
- University of Michigan, School of Public Health. (1)
- University of Michigan. School of Medicine. (1)
- University of Michigan School of Medicine. (1)
- University of Michigan School of Public Health. (3)
- University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. (1)
- University of Utah. (1)
- University of Washington School of Medicine. (3)
- Vanderbilt University Medical Center, Nashville, Tennessee. (1)
- Vanderbilt University Medical Center. (4)
- Wake Forest University. Baptist Medical Center. (1)
- Wake Forest University Baptist Medical Center. (3)
- Washington University. (2)
- Alabama (1)
- Arizona (1)
- California (1)
- Colorado (2)
- Davidson County, TN (1)
- Florida (1)
- Georgia (1)
- Indiana (1)
- Iowa (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (2)
- Massachusetts (1)
- Michigan (1)
- Minnesota (2)
- Missouri (1)
- New Mexico (1)
- New York (1)
- New York City, NY (1)
- North Carolina (2)
- Ohio (1)
- Oregon (1)
- Peru (1)
- Reactogenicity and immunogenicity of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant and nonpregnant women ☆ (1)
- Seattle, WA (1)
- Tennessee (10)
- Texas (1)
- United States (11)
- Utah (2)
- Washington (1)
- Wisconsin (3)
- Acute Disease (1)
- adherence (1)
- Bronchiolitis (1)
- Chest (1)
- Child, Preschool (1)
- Children (1)
- COVID-19 (1)
- death (1)
- epidemiology (1)
- etiology (1)
- Female (1)
- hospitalization (1)
- household transmission (1)
- Human metapneumovirus (1)
- Humans (1)
- incidence (1)
- Infant (1)
- Infant, Newborn (1)
- Infection (1)
- Lungs (1)
- Male (1)
- Metapneumovirus (1)
- palivizumab (1)
- Paramyxoviridae Infections (1)
- pediatric (1)
- pneumonia (1)
- Prospective Studies (1)
- Radiography (1)
- Radiography, Thoracic (1)
- respiratory syncytial virus (1)
- Respiratory tract (1)
- Respiratory Tract Infections (1)
- SARS-CoV-2 (2)
- secondary infection risk (1)
- severe disease (1)
- viral culture (1)
- :Edwards, Kathryn M. ;Zhu, YuweiFeb 14 2013 | N Engl J Med. 2013; 368(7):633-643:BACKGROUNDThe inpatient and outpatient burden of human metapneumovirus (HMPV) infection among young children has not been well established.METHODSWe c...
- :Pratt, Caroline Quinn ;Zhu, YuweiDecember 17 2018 | Influenza Other Respir Viruses. 13(2):208-212:Ninety-five adults enrolled in the Etiology of Pneumonia in the Community study with negative admission influenza polymerase chain reaction (PCR) test...
- :Fortner, Kimberly B. ;Swamy, Geeta K.September 13 2018 | Vaccine. 36(42):6354-6360:Objective:Tetanus toxoid, reduced diphtheria toxoid, and acellular pertusiss (Tdap) vaccine is recommended during each pregnancy, regardless of prior ...
- :Grijalva, Carlos G. ;Zhu, YuweiNov 30 2010 | PLoS One. 5(11).:BackgroundThe optimal vaccination strategy to mitigate the impact of influenza epidemics is unclear. In 2005, a countywide school-based influenza vacc...
- :Talbot, H. Keipp ;Coleman, Laura A.Apr 23 2015 | BMC Infect Dis. 15.:BackgroundLittle is known about factors associated with maintenance of hemagglutinin inhibition (HAI) antibodies after influenza vaccination in older ...
- :Hartman, Lauren ;Zhu, YuweiFebruary 13 2018 | J Am Geriatr Soc. 66(3):467-472:ObjectiveTo describe factors associated with provider-ordered influenza testing among hospitalized adults.DesignInformation on patient demographics, s...
- :Shing, Jaimie Z. ;Hull, Pamela C.April 10 2019 | Papillomavirus Res. 2019; 7:141-149:IntroductionEvidence of human papillomavirus (HPV) vaccine impact on anogenital warts (AGWs) by race or urbanicity in the US is lacking. We evaluated ...
- :Griffin, Marie R. ;Zhu, Yuwei7 11 2013 | N Engl J Med. 369(2):155-163:BackgroundThe introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the US childhood immunization schedule in 2000 has substantially red...
- :Jain, Seema ;Williams, Derek J.2 26 2015 | N Engl J Med. 372(9):835-845:BackgroundU.S. incidence estimates of pediatric community-acquired pneumonia hospitalizations based on prospective data collection are limited. Update...
- :Grijalva, Carlos G. ;Zhu, YuweiMay 26 2011 | Thorax. 66(8):663-668.:BACKGROUNDAlthough recent reports suggest the incidence of parapneumonic empyema increased in several regions of the United States, national trends in...
- :Grijalva, Carlos G. ;Zhu, YuweiOct 13 2015 | JAMA. 314(14):1488-1497:ImportanceFew studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection.Objec...
- :Hilmes, Melissa A. ;Dunnavant, F. Daniel12 2017 | Pediatr Radiol. 47(13):1745-1750:BackgroundHuman metapneumovirus (HMPV) was identified in 2001 and is a common cause of acute respiratory illness in young children. The radiologic cha...
- :Self, Wesley H. ;Grijalva, Carlos G.May 2012 | Emerg Infect Dis. 18(5):863-865.:To determine the number of emergency department visits attributable to influenza A(H1N1)pdm09 in Davidson County, Tennessee, USA, we used active, popu...
- :Octaria, Rany ;Chan, AllisonSep 2020 | Emerg Infect Dis. 26(9):2046-2053:To identify facilities at risk of receiving patients colonized or infected with multidrug-resistant organisms (MDROs), we developed an interactive web...
- :Fan, Roger R. ;Howard, Leigh M.Nov 2016 | Emerg Infect Dis. 22(11):1996-1999.:We examined nasopharyngeal pneumococcal colonization density patterns surrounding acute respiratory illnesses (ARI) in young children in Peru. Pneumoc...
- :Wiese, Andrew D. ;Grijalva, Carlos G.Jun 2016 | Emerg Infect Dis. 22(6):1109-1112.:Introduction of pneumococcal conjugate vaccines in the childhood immunization schedule was associated with decreases in all-cause pneumonia hospitaliz...
- :Petrie, Joshua G. ;Martin, Emily T.6 27 2019 | Vaccine. 37(29):3849-3855:Background:Frailty is an important physiologic factor in studies of influenza and influenza vaccines carried out in older adults and hospitalized popu...
- :Widmer, Kyle ;Griffin, Marie R.Feb 07 2014 | Influenza Other Respir Viruses. 8(3):347-352.:BackgroundLittle is known about the burden of illness associated with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in adults, es...
- :Jules, Astride ;Grijalva, Carlos G.Feb 23 2012 | Influenza Other Respi Viruses. 2012; 6(3):e63-e71.:BackgroundIn April 2009, a pandemic caused by a novel influenza strain, the A(H1N1)pdm09 virus, started. Few age-specific estimates of hospitalization...
- :Dare, Ryan ;Zhu, YuweiApr 26 2016 | J Med Virol. 88(11):1891-1895.:BackgroundSample processing for real-time reverse transcriptase polymerase chain reaction (rRT-PCR) based diagnostic assays requires stabilizing sampl...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.